Financials
- Market Capitalization 5.54 B
- Employee 92
- Founded 2019
- CEO N/A
- Website www.dianthustx.com
- Headquarter Delaware, United States
- FIGI BBG00FB2NPZ0
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-19.84
Fiyat/satışlar oranı
547.28
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 1221 | LGND Ligand Pharmaceuticals Incorporated - Common Stock | 300.97 USD | -2.68% | -6.50% | +17.98% | +60.84% | 6.03 B USD | ||
| 1250 | BLTE Belite Bio Inc - American Depositary Shares | 146.68 USD | -0.24% | -5.67% | +1.17% | +132.42% | 5.77 B USD | ||
| 1286 | CELC Celcuity Inc. - Common Stock | 111.05 USD | +6.99% | -2.59% | +25.42% | +700.65% | 5.42 B USD | ||
| 1299 | TVTX Travere Therapeutics, Inc. - Common Stock | 57.06 USD | +1.37% | -0.77% | +5.90% | +98.33% | 5.31 B USD |